Oral immunization with cholera toxin provides protection against Campylobacter jejuni in an adult mouse intestinal colonization model

mBio

Volumn 4, Issue 3, 2013, Pages

  Albert, M John ^a   Mustafa, Abu Salim ^a   Islam, Anjum ^a   Haridas, Shilpa ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; OUTER MEMBRANE PROTEIN; TOXIN ANTIBODY; BACTERIUM ANTIBODY; CHOLERA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL SHEDDING; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BLOOD ANALYSIS; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; CROSS REACTION; DRUG EFFICACY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CAMPYLOBACTER INFECTIONS; CHEMISTRY; CROSS PROTECTION; FECES; IMMUNOLOGY; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PROCEDURES; RABBIT;

ANIMALIA; CAMPYLOBACTER JEJUNI; MUS; ORYCTOLAGUS CUNICULUS;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL SHEDDING; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CHOLERA TOXIN; CHOLERA VACCINES; CROSS PROTECTION; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; IMMUNIZATION; IMMUNOBLOTTING; MICE; MICE, INBRED BALB C; RABBITS;

EID: 84879596745     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00246-13     Document Type: Article

References (36)

1. Newell DG, Koopmans M, Verhoef L, Duizer E, Aidara-Kane A, Sprong H, Opsteegh M, Langelaar M, Threfall J, Scheutz F, van der Giessen J, Kruse H. 2010. Food-borne diseases-the challenge of 20 years ago still persists while new ones continue to emerge. Int. J. Food Microbiol. 139(Suppl 1):S3-S15. http://dx.doi.org/10.1016/j.ijfoodmicro.2010.01.021.
2. Friedman CR, Neimann J, Wegener HC, Tauxe RV. 2000. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations, p 121-138. In Nachamkin I, Blaser MJ (ed), Campylobacter, 2nd ed. ASM Press, Washington, DC.
3. Oberhelman RA, Taylor DN. 2000. Campylobacter infections in developing countries, p 139-154. In Nachamkin I, Blaser MJ (ed), Campylobacter, 2nd ed. ASM Press, Washington, DC.
4. Blaser MJ. 1997. Epidemiologic and clinical features of Campylobacter jejuni infections. J. Infect. Dis. 176(Suppl 2):S103-S105.
5. Buzby JC, Allos BM, Roberts T. 1997. The economic burden of Campylobacter-associated Guillain-Barré syndrome. J. Infect. Dis. 176(Suppl 2):S192-S197.
6. Scott DA. 1997. Vaccines against Campylobacter jejuni. J. Infect. Dis. 176(Suppl 2):S183-S188.
7. World Health Organization. 2005. State of the art of vaccine research and development. WHO/IVB/05.xx. World Health Organization, Geneva, Switzerland.
8. Taylor D. 1992. Campylobacter infections in developing countries, p 20-30. In Nachamkin I, Blaser M, Tomkins L (ed), Campylobacter jejuni: current status and future trends. ASM Press, Washington, DC.
9. Taylor DN, Perlman DM, Echeverria PD, Lexomboon U, Blaser MJ. 1993. Campylobacter immunity and quantitative excretion rates in Thai children. J. Infect. Dis. 168:754-758.
10. Black R, Perlman D, Clements M, Levine M, Blaser M. 1992. Human volunteer studies with Campylobacter jejuni, p 207-215. In Nachamkin I, Blaser M, Tomkins L (ed), Campylobacter jejuni: current status and future trends. ASM Press, Washington, DC.
11. Burr DH, Caldwell MB, Bourgeois AL, Morgan HR, Wistar R, Jr, Walker RI. 1988. Mucosal and systemic immunity to Campylobacter je juni in rabbits after gastric inoculation. Infect. Immun. 56:99-105.
12. Pavlovskis OR, Rollins DM, Haberberger GAE, Jr, Habash L, Strocko S, Walker RI. 1991. Significance of flagella in colonization resistance of rabbits immunized with Campylobacter spp. Infect. Immun. 59: 2259-2264.
13. Karlyshev AV, Linton D, Gregson NA, Lastovica AJ, Wren BW. 2000. Genetic and biochemical evidence of a Campylobacter jejuni capsular poly-saccharide that accounts for Penner serotype specificity. Mol. Microbiol. 35:529-541.
14. Albert MJ, Haridas S, Steer D, Dhaunsi GS, Smith AI, Adler B. 2007. Identification of a Campylobacter jejuni protein that cross-reacts with cholera toxin. Infect. Immun. 75:3070-3073.
15. Gill DM. 1977. Mechanism of action of cholera toxin. Adv. Cyclic Nucleotide Res. 8:85-118.
16. Hill DR, Ford L, Lalloo DG. 2006. Oral cholera vaccines: use in clinical practice. Lancet Infect. Dis. 6:361-373.
17. Blaser MJ, Duncan DJ, Warren GH, Wang WL. 1983. Experimental Campylobacter jejuni infection in adult mice. Infect. Immun. 39:908-916.
18. Baqar S, Applebee LA, Bourgeois AL. 1995. Immunogenicity and protective efficacy of a prototype Campylobacter killed whole-cell vaccine in mice. Infect. Immun. 63:3731-3735.
19. Berndtson E, Danielsson-Tham ML, Engvall A. 1994. Experimental colonization of mice with Campylobacterjejuni. Vet. Microbiol. 41: 183-188.
20. Islam A, Raghupathy R, Albert MJ. 2010. Recombinant PorA, the major outer membrane protein of Campylobacter jejuni, provides heterologous protection in an adult mouse intestinal colonization model. Clin. Vaccine Immunol. 17:1666-1671.
21. Pei Z, Burucoa C, Grignon B, Baqar S, Huang XZ, Kopecko DJ, Bourgeois AL, Fauchere JL, Blaser MJ. 1998. Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice. Infect. Immun. 66:938-943.
22. Haneberg B, Kendall D, Amerongen HM, Apter FM, Kraehenbuhl JP, Neutra MR. 1994. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect. Immun. 62: 15-23.
23. Baqar S, Pacheco ND, Rollwagen FM. 1993. Modulation of mucosal immunity against Campylobacter jejuni by orally administered cytokines. Antimicrob. Agents Chemother. 37:2688-2692.
24. Trautmann M, Held TK, Susa M, Karajan MA, Wulf A, Cross AS, Marre R. 1998. Bacterial lipopolysaccharide (LPS)-specific antibodies in commercial human immunoglobulin preparations: superior antibody content of an IgM-enriched product. Clin. Exp. Immunol. 111:81-90.
25. Jagusztyn-Krynicka EK, Laniewski P, Wyszyńska A. 2009. Update on Campylobacter jejuni vaccine development for preventing campylobacteriosis. Expert Rev. Vaccines 8:625-645.
26. Lee LH, Burg E, III, Baqar S, Bourgeois AL, Burr DH, Ewing CP, Trust TJ, Guerry P. 1999. Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuni. Infect. Immun. 67:5799-5805.
27. Prokhorova TA, Nielsen PN, Petersen J, Kofoed T, Crawford JS, Morsczeck C, Boysen A, Schrotz-King P. 2006. Novel surface polypeptides of Campylobacter jejuni as travellers' diarrhea vaccine candidates discovered by proteomics. Vaccine 24:6446-6455.
28. Baqar S, Applebee LA, Gilliland TC, Jr, Lee LH, Porter CK, Guerry P. 2008. Immunogenicity and protective efficacy of recombinant Campylobacter jejuni flagellum-secreted proteins in mice. Infect. Immun. 76: 3170-3175.
29. Monteiro MA, Baqar S, Hall ER, Chen YH, Porter CK, Bentzel DE, Applebee L, Guerry P. 2009. Capsule polysaccharide conjugate vaccine against diarrheal disease caused by Campylobacter jejuni. Infect. Immun. 77:1128-1136.
30. Sizemore DR, Warner B, Lawrence J, Jones A, Killeen KP. 2006. Live, attenuated Salmonella typhimurium vectoring Campylobacter antigens. Vaccine 24:3793-3803.
31. Zhang Q, Meitzler JC, Huang S, Morishita T. 2000. Sequence polymorphism, predicted secondary structures, and surface-exposed conformational epitopes of Campylobacter major outer membrane protein. Infect. Immun. 68:5679-5689.
32. Albert MJ, Haridas S, Adler B. 2008. Major outer membrane proteins from many Campylobacter species cross-react with cholera toxin. Clin. Vaccine Immunol. 15:859-862.
33. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
34. Jertborn M, Nordström I, Kilander A, Czerkinsky C, Holmgren J. 2001. Local and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humans. Infect. Immun. 69: 4125-4128.
35. Al-Khodari NY, Al-Attiyah R, Mustafa AS. 2011. Identification, diagnostic potential, and natural expression of immunodominant seroreactive peptides encoded by five Mycobacterium tuberculosis-specific genomic regions. Clin. Vaccine Immunol. 18:477-482.
36. Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, Basham D, Chillingworth T, Davies RM, Feltwell T, Holroyd S, Jagels K, Karlyshev AV, Moule S, Pallen MJ, Penn CW, Quail MA, Rajandream MA, Rutherford KM, van Vliet AH, Whitehead S, Barrell BG. 2000. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403:665-668.